Literature DB >> 32198555

18F-FDG PET/CT in bone sarcoidosis: an observational study.

Lucie Demaria1, Raphael Borie2, Khadija Benali3, Eve Piekarski3, Julia Goossens1, Elisabeth Palazzo1, Marine Forien1, Philippe Dieudé1, Bruno Crestani2, Sébastien Ottaviani4.   

Abstract

OBJECTIVE: Bone sarcoidosis is usually rare. Imaging procedures such as fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) can reveal bone sarcoidosis with better sensitivity than conventional radiography. We aimed to describe bone sarcoidosis involvement detected with 18F-FDG PET/CT.
METHODS: This was an observational retrospective study of individuals with pulmonary sarcoidosis who underwent 18F-FDG PET/CT. According to the ATS/ERS/WASOG criteria, sarcoidosis was diagnosed by the presence of clinical and/or imaging features of sarcoidosis and evidence of non-caseating epithelioid granulomas on a biopsy. We assessed clinical and 18F-FDG PET/CT characteristics.
RESULTS: Data for 85 patients with sarcoidosis (56.5% female, median age 47 [range 21-80] years) were analyzed. The median follow-up was 4 years. Among 56 patients, sarcoidosis occurred in more than three organs. According to ATS/ERS/WASOG criteria, bone sarcoidosis was diagnosed in 12 (14%) patients. The spine was the most commonly affected location (92%, n = 11), followed by the pelvis (67%, n = 8), sternum (33%, n = 4), humerus (25%, n = 3), and fingers (17%, n = 2). Only peripheral adenopathy was associated with bone sarcoidosis (p = 0.04). Seven patients had a 18F-FDG PET/CT follow-up, all showing a decrease of bone lesions.
CONCLUSION: Bone sarcoidosis occurred in 14% of patients with sarcoidosis, affecting multiple bones and mostly the axial skeleton. 18F-FDG PET/CT seems a sensitive tool for diagnosis and follow-up of bone sarcoidosis.

Entities:  

Keywords:  18F-FDG PET/CT; Bone; Sarcoidosis

Mesh:

Substances:

Year:  2020        PMID: 32198555     DOI: 10.1007/s10067-020-05022-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  10 in total

1.  FDG positron emission tomography of bone involvement in sarcoidosis.

Authors:  Caroline Aberg; Fabio Ponzo; Bruce Raphael; Edward Amorosi; Victor Moran; Elissa Kramer
Journal:  AJR Am J Roentgenol       Date:  2004-04       Impact factor: 3.959

2.  F-18 FDG PET/CT for detecting bone and bone marrow involvement in sarcoidosis patients.

Authors:  Rémy L Mostard; Léonne Prompers; Rene E Weijers; Marinus J van Kroonenburgh; Petal A Wijnen; Piet P Geusens; Marjolein Drent
Journal:  Clin Nucl Med       Date:  2012-01       Impact factor: 7.794

3.  PET positivity with bone marrow biopsy revealing sarcoidosis in a patient in whom bone marrow metastases had been suspected.

Authors:  Simone Baldini; Alberto Pupi; Simonetta Di Lollo; Niccolò Marchionni; Riyad Shraim; Alberto Bosi
Journal:  Br J Haematol       Date:  2008-07-30       Impact factor: 6.998

4.  FDG PET/CT in bone sarcoidosis.

Authors:  Isidora Grozdic Milojevic; Dragana Sobic-Saranovic; Jelica Videnovic-Ivanov; Djordjije Saranovic; Strahinja Odalovic; Vera Artiko
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2016-03-29       Impact factor: 0.670

5.  Osseous sarcoidosis: clinical characteristics, treatment, and outcomes--experience from a large, academic hospital.

Authors:  Jeffrey A Sparks; Jakob I McSparron; Nehal Shah; Piran Aliabadi; Vera Paulson; Christopher H Fanta; Jonathan S Coblyn
Journal:  Semin Arthritis Rheum       Date:  2014-07-15       Impact factor: 5.532

6.  Sarcoidosis involving the musculoskeletal system.

Authors:  David A Zisman; Andrew F Shorr; Joseph P Lynch
Journal:  Semin Respir Crit Care Med       Date:  2002-12       Impact factor: 3.119

7.  Unsuspected skeletal sarcoidosis mimicking metastatic disease on FDG positron emission tomography and bone scintigraphy.

Authors:  Vinicius Ludwig; Sarina Fordice; Ruth Lamar; William H Martin; Dominique Delbeke
Journal:  Clin Nucl Med       Date:  2003-03       Impact factor: 7.794

8.  Diffuse spine involvement in sarcoidosis with sternal lytic lesions: two case reports.

Authors:  Frédéric Clarençon; Olivia Silbermann-Hoffman; Caroline Lebreton; Pédro Fernandez; Khaldoun Kerrou; Sylvain Marchand-Adam; Muriel Hourseau; Elisabeth Schouman-Claeys; Antoine Feydy
Journal:  Spine (Phila Pa 1976)       Date:  2007-09-15       Impact factor: 3.468

9.  Osteoarticular involvement in a series of 100 patients with sarcoidosis referred to rheumatology departments.

Authors:  Natacha Thelier; Noémie Assous; Chantal Job-Deslandre; Olivier Meyer; Thomas Bardin; Philippe Orcel; Frédéric Lioté; Maxime Dougados; Andre Kahan; Yannick Allanore
Journal:  J Rheumatol       Date:  2008-07-15       Impact factor: 4.666

10.  Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients.

Authors:  Kyoichi Kaira; Noboru Oriuchi; Yoshimi Otani; Noriko Yanagitani; Noriaki Sunaga; Takeshi Hisada; Tamotsu Ishizuka; Keigo Endo; Masatomo Mori
Journal:  Chest       Date:  2007-04       Impact factor: 9.410

  10 in total
  2 in total

1.  Usefulness of position emission tomography/computed tomography in a case of sarcoidosis with multiorgan involvement.

Authors:  Norihiko Amano; Soshi Takahashi; Saori Hatachi; Shunichi Kumagai
Journal:  Clin Case Rep       Date:  2022-02-13

Review 2.  Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis.

Authors:  Pascal Sève; Yves Pacheco; François Durupt; Yvan Jamilloux; Mathieu Gerfaud-Valentin; Sylvie Isaac; Loïc Boussel; Alain Calender; Géraldine Androdias; Dominique Valeyre; Thomas El Jammal
Journal:  Cells       Date:  2021-03-31       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.